IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
419.83
-1.08 (-0.26%)
Nov 18, 2024, 4:00 PM EST - Market closed
IDEXX Laboratories Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for IDEXX Laboratories stock have an average target of 545.29, with a low estimate of 435 and a high estimate of 650. The average target predicts an increase of 29.88% from the current stock price of 419.83.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IDXX stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Reiterates $520 → $435 | Hold | Reiterates | $520 → $435 | +3.61% | Nov 4, 2024 |
| Barclays | Barclays | Buy Maintains $570 → $481 | Buy | Maintains | $570 → $481 | +14.57% | Nov 4, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $630 → $575 | Buy | Maintains | $630 → $575 | +36.96% | Oct 11, 2024 |
| Stifel | Stifel | Hold Maintains $510 → $500 | Hold | Maintains | $510 → $500 | +19.10% | Oct 10, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $600 → $520 | Hold | Maintains | $600 → $520 | +23.86% | Aug 14, 2024 |
Financial Forecast
Revenue This Year
3.96B
from 3.66B
Increased by 8.03%
Revenue Next Year
4.23B
from 3.96B
Increased by 6.98%
EPS This Year
10.76
from 10.06
Increased by 7.00%
EPS Next Year
12.20
from 10.76
Increased by 13.37%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.1B | 4.4B | 4.8B | ||
| Avg | 4.0B | 4.2B | 4.6B | ||
| Low | 3.8B | 4.0B | 4.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.4% | 11.3% | 14.3% | ||
| Avg | 8.0% | 7.0% | 8.7% | ||
| Low | 3.6% | 1.1% | 1.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.59 | 12.87 | 15.84 | ||
| Avg | 10.76 | 12.20 | 13.93 | ||
| Low | 10.17 | 11.25 | 12.92 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 15.2% | 19.6% | 29.8% | ||
| Avg | 7.0% | 13.4% | 14.1% | ||
| Low | 1.1% | 4.5% | 5.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.